N-glycosylation pattern of recombinant human CD82 (KAI1), a tumor-associated membrane protein

Journal of Proteomics

Volumn 75, Issue 4, 2012, Pages 1375-1385

  Wang, Hong ^a   Zhang, Wei ^a   Zhao, Jian ^a   Zhang, Lei ^a   Liu, Mingqi ^a   Yan, Guoquan ^a   Yao, Jun ^a   Yu, Hongxiu ^a   Yang, Pengyuan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

CD82 (KAI1); Glycosylation; Membrane protein

Indexed keywords

(ALPHA 2,6) N ACETYLNEURAMINIC ACID; ASPARAGINE; CARBOHYDRATE ANTIGEN; CD82 ANTIGEN; CORE FUCOSE; FUCOSE; GLYCAN; GLYCOSIDASE; LECTIN; N ACETYLGLUCOSAMINE; N ACETYLNEURAMINIC ACID DERIVATIVE; PROTEINASE; RECOMBINANT CD82 PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; CELL ADHESION; CONTROLLED STUDY; GLYCOBIOLOGY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; PROTEIN METABOLISM; PROTEIN METHYLATION; PROTEOMICS; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANTIGENS, CD82; CELL MEMBRANE; CHROMATOGRAPHY, LIQUID; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION; HEK293 CELLS; HUMANS; LECTINS; MASS SPECTROMETRY; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEOPLASM METASTASIS; PEPTIDE HYDROLASES; POLYSACCHARIDES; PROTEOMICS; RECOMBINANT PROTEINS;

EID: 84855883197     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.11.013     Document Type: Article

References (41)

1. Boucheix C., Rubinstein E. Tetraspanins. Cell Mol Life Sci 2001, 58:1189-1205.
2. Zoller M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 2009, 9:40-55.
3. Tonoli H., Barrett J.C. CD82 metastasis suppressor gene: a potential target for new therapeutics?. Trends Mol Med 2005, 11:563-570.
4. Vogt A.B., Spindeldreher S., Kropshofer H. Clustering of MHC-peptide complexes prior to their engagement in the immunological synapse: lipid raft and tetraspan microdomains. Immunol Rev 2002, 189:136-151.
5. Zhou B., Liu L., Reddivari M., Zhang X.A. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity. Cancer Res 2004, 64:7455-7463.
6. White A., Lamb P.W., Barrett J.C. Frequent downregulation of the KAI1 (CD82) metastasis suppressor protein in human cancer cell lines. Oncogene 1998, 16:3143-3149.
7. Ono M., Handa K., Withers D.A., Hakomori S. Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells. Biochem Biophys Res Commun 2000, 279:744-750.
8. Ono M., Handa K., Withers D.A., Hakomori S. Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. Cancer Res 1999, 59:2335-2339.
9. Tan S., Tan H.T., Chung M.C. Membrane proteins and membrane proteomics. Proteomics 2008, 8:3924-3932.
10. Lotan R., Nicolson G.L. Purification of cell membrane glycoproteins by lectin affinity chromatography. Biochim Biophys Acta 1979, 559:329-376.
11. Lee A., Kolarich D., Haynes P.A., Jensen P.H., Baker M.S., Packer N.H. Rat liver membrane glycoproteome: enrichment by phase partitioning and glycoprotein capture. J Proteome Res 2009, 8:770-781.
12. Andre M., Morelle W., Planchon S., Milhiet P.E., Rubinstein E., Mollicone R., et al. Glycosylation status of the membrane protein CD9P-1. Proteomics 2007, 7:3880-3895.
13. Tie J.K., Zheng M.Y., Pope R.M., Straight D.L., Stafford D.W. Identification of the N-linked glycosylation sites of vitamin K-dependent carboxylase and effect of glycosylation on carboxylase function. Biochemistry 2006, 45:14755-14763.
14. Wedepohl S., Kaup M., Riese S.B., Berger M., Dernedde J., Tauber R., et al. N-glycan analysis of recombinant L-selectin reveals sulfated GalNAc and GalNAc GalNAc motifs. J Proteome Res 2010, 9:3403-3411.
15. Zhao J., Liu Y.H., Reichert P., Pflanz S., Pramanik B. Glycosylation analysis of interleukin-23 receptor: elucidation of glycosylation sites and characterization of attached glycan structures. J Mass Spectrom 2010, 45:1416-1425.
16. Zhang X.A., Lane W.S., Charrin S., Rubinstein E., Liu L. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate. Cancer Res 2003, 63:2665-2674.
17. Liu Z., Cao J., He Y.F., Qiao L., Xu C., Lu H., et al. Tandem 18O stable isotope labeling for quantification of N-glycoproteome. J Proteome Res 2010, 9:227-236.
18. Kuster B., Wheeler S.F., Hunter A.P., Dwek R.A., Harvey D.J. Sequencing of N-linked oligosaccharides directly from protein gels: in-gel deglycosylation followed by matrix-assisted laser desorption/ionization mass spectrometry and normal-phase high-performance liquid chromatography. Anal Biochem 1997, 250:82-101.
19. Costello C.E., Contado-Miller J.M., Cipollo J.F. A glycomics platform for the analysis of permethylated oligosaccharide alditols. J Am Soc Mass Spectrom 2007, 18:1799-1812.
20. Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M., Schiess R., et al. Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat Biotechnol 2009, 27:378-386.
21. Vogel C., Marcotte E.M. Calculating absolute and relative protein abundance from mass spectrometry-based protein expression data. Nat Protoc 2008, 3:1444-1451.
22. Chen R., Jiang X.N., Sun D.G., Han G.H., Wang F.J., Ye M.L., et al. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res 2009, 8:651-661.
23. O'Neill R.A. Enzymatic release of oligosaccharides from glycoproteins for chromatographic and electrophoretic analysis. J Chromatogr A 1996, 720:201-215.
24. Brewer C.F., Bhattacharyya L., Brown R.D., Koenig S.H. Interactions of concanavalin A with a trimannosyl oligosaccharide fragment of complex and high mannose type glycopeptides. Biochem Biophys Res Commun 1985, 127:1066-1071.
25. Debray N., Decout D., Strecker G., Spik G., Montreuil J. Specificity of twelve lectins towards oligosaccharides and glycopeptides related to N-glycosylproteins. Eur J Biochem 1981, 117:41-55.
26. Osawa T., Tsuji T. Fractionation and structural assessment of oligosaccharides and glycopeptides by use of immobilized lectins. Annu Rev Biochem 1987, 56:21-42.
27. Shibuya N., Goldstein I.J., Broekaert W.F., Nsimba-Lubaki M., Peeters B., Peumans W.J. The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac (alpha 2-6) Gal/GalNAc sequence. J Biol Chem 1987, 262:1596-1601.
28. Knibbs R.N., Agrwal N., Wang J.L., Goldstein I.J. Carbohydrate-binding protein 35. II. Analysis of the interaction of the recombinant polypeptide with saccharides. J Biol Chem 1993, 268:14940-14947.
29. Lotan R., Skuttelsky E., Danon D., Sharon N. The purification, composition and specificity of the anti-T lectin from peanut (Arachishypogaea). J Biol Chem 1975, 250:8518-8523.
30. Morelle W., Faid V., Michalski J.C. Structural analysis of permethylated oligosaccharides using electrospray ionization quadrupole time-of-flight tandem mass spectrometry and deutero-reduction. Rapid Commun Mass Spectrom 2004, 18:2451-2464.
31. Ceroni A., Maass K., Geyer H., Geyer R., Dell A., Haslam S.M. GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans. J Proteome Res 2008, 7:1650-1659.
32. Ashline D.J., Lapadula A.J., Liu Y.H., Lin M., Grace M., Pramanik B., et al. Carbohydrate structural isomers analyzed by sequential mass spectrometry. Anal Chem 2007, 79:3830-3842.
33. Ciucanu I., Costello C.E. Elimination of oxidative degradation during the per-O-methylation of carbohydrates. J Am Chem Soc 2003, 125:16213-16219.
34. 18O into glycans for relative glycan quantitation. Anal Chem 2011, 83:4975-4981.
35. Granovsky M., Fata J., Pawling J., Muller W.J., Khokha R., Dennis J.W. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med 2000, 6:306-312.
36. Zhao Y., Sato Y., Isaji T., Fukuda T., Matsumoto A., Miyoshi E., et al. Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J 2008, 275:1939-1948.
37. Varki N.M., Varki A. Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab Invest 2007, 87:851-857.
38. Tokuyama S., Moriya S., Taniguchi S., Yasui A., Miyazaki J., Orikasa S., et al. Suppression of pulmonary metastasis in murine B16 melanoma cells by transfection of a sialidase cDNA. Int J Cancer 1997, 73:410-415.
39. Miyoshi E., Noda K., Ko J.H., Ekuni A., Kitada T., Uozumi N., et al. Overexpression of alpha1-6 fucosyltransferase in hepatoma cells suppresses intrahepatic metastasis after splenic injection in athymic mice. Cancer Res 1999, 59:2237-2243.
40. Takahashi T., Ueda Y., Miyoshi E., Yaginuma Y., Ishikawa M., Taniguchi N. Alpha 1,6-Fucosyltransferase is highly and specifically expressed in human ovarian serous adenocarcinomas. Int J Cancer 2000, 88:914-919.
41. Takahashi M., Kuroki Y., Ohtsubo K., Taniguchi N. Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins. Carbohydr Res 2009, 344:1387-1390.